Home › Research › Tau biomarkers
In vivo Prevalence of Alzheimer Biomarkers in Dementia with Lewy Bodies
Paraskevas GP, Bougea A, Constantinides VC, Bourbouli M, Petropoulou O, Kapaki E.. Dementia and geriatric cognitive disorders, 2019-07-16
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background Neuropathological studies indicate concomitant Alzheimer's disease (AD) pathology in patients with dementia with Lewy bodies (DLB). Objectives To measure cerebrospinal fluid (CSF) levels of β-amyloid peptide with 42 amino acids (Aβ42), total tau protein (τT), and tau phosphorylated at threonine 181 (τP-181) in 38 patients fulfilling the diagnostic criteria of probable DLB according to the most recent (4th consensus) report. Methods Double-sandwich commercial ELISAs (Innotest; Fujirebio, Gent, Belgium) were used for measurements.
What this study adds
Evidence grade: Low
The record lists 38 participants. This study measured cerebrospinal fluid Aβ42, total tau and tau phosphorylated at threonine 181 in 38 patients with probable dementia with Lewy bodies to see how often Alzheimer's biomarker profiles appear. Reported effect size: 44.7%; 39.5%; 5.3%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Paraskevas, G. P., Bougea, A., Constantinides, V. C., Bourbouli, M., Petropoulou, O., & Kapaki, E. (2019). In vivo Prevalence of Alzheimer Biomarkers in Dementia with Lewy Bodies. Dementia and geriatric cognitive disorders. https://doi.org/10.1159/000500567
Vancouver
Paraskevas GP, Bougea A, Constantinides VC, Bourbouli M, Petropoulou O, Kapaki E. In vivo Prevalence of Alzheimer Biomarkers in Dementia with Lewy Bodies. Dementia and geriatric cognitive disorders. 2019. doi:10.1159/000500567. PMID: 31311013.
BibTeX
@article{paraskevas2019-31311013,
author = {Paraskevas, G. P. and Bougea, A. and Constantinides, V. C. and Bourbouli, M. and Petropoulou, O. and Kapaki, E.},
title = {{In vivo Prevalence of Alzheimer Biomarkers in Dementia with Lewy Bodies}},
journal = {Dementia and geriatric cognitive disorders},
year = {2019},
doi = {10.1159/000500567},
pmid = {31311013},
url = {https://doi.org/10.1159/000500567}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Objectives To measure cerebrospinal fluid (CSF) levels of β-amyloid peptide with 42 amino acids (Aβ42), total tau protein (τT), and tau phosphorylated at threonine 181 (τP-181) in 38 patients fulfilling the diagnostic criteria of probable DLB according to the most recent (4th consensus) report.
- Methods Double-sandwich commercial ELISAs (Innotest; Fujirebio, Gent, Belgium) were used for measurements.
- Results According to the current cutoff values of our laboratory, 4 biomarker profiles were noted: abnormal levels of Aβ42 only (44.7%), full AD profile (39.5%), abnormal levels of τT only (5.3%), and normal levels of all 3 biomarkers (10.5%).
- AD profile was associated with female sex, older age, lower education, and lower MMSE scores.
Why it matters
This study measured cerebrospinal fluid Aβ42, total tau and tau phosphorylated at threonine 181 in 38 patients with probable dementia with Lewy bodies to see how often Alzheimer's biomarker profiles appear. It is a biomarker prevalence study, so it does not provide a treatment, cure or prevention.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants38
- Effect size44.7%; 39.5%; 5.3%
- Evidence strengthLow
How this study scored 42/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Dementia and geriatric cognitive disorders) |
| Journal's citation record | 1 / 4 | Dementia and Geriatric Cognitive Disorders: journal h-index 149 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2019 — within 10 year(s) of the newest study here |
| Sample size | 1 / 4 | 38 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 18 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.0 citations a year over 9 year(s) since 2019 |
| Impact for its field and year | 2 / 6 | Cited 1.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 4 other studies in this library |
| Still being cited | 1 / 4 | Cited 8 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Elisabeth N. Kapaki: h-index 34 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | National and Kapodistrian University of Athens: institution h-index 859 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 31311013) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 42 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 16.
Later studies that cite this one
4 studies in the alzhub library list this one in their references.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.